Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia. | Orphanet J Rare Dis | 2022 | 35854323 | PubTator, text mining | PubMed |
| LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms. | Nucleic Acids Res | 2022 | 35849344 | Swiss-Prot, curated | PubMed |
| Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases. | Front Cell Neurosci | 2022 | 35846567 | PubTator, text mining | PubMed |
| Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study. | Cancer Res | 2022 | 35834270 | PubTator, text mining | PubMed |
| Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial. | Lancet Oncol | 2022 | 35810751 | PubTator, text mining | PubMed |
| Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management. | Int J Mol Sci | 2022 | 35806485 | PubTator, text mining | PubMed |
| Extraterrestrial Gynecology: Could Spaceflight Increase the Risk of Developing Cancer in Female Astronauts? An Updated Review. | Int J Mol Sci | 2022 | 35806469 | PubTator, text mining | PubMed |
| Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes. | Int J Mol Sci | 2022 | 35806449 | PubTator, text mining | PubMed |
| Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways. | Int J Mol Sci | 2022 | 35806337 | PubTator, text mining | PubMed |
| Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes. | Int J Environ Res Public Health | 2022 | 35805770 | PubTator, text mining | PubMed |
| Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. | Cancers (Basel) | 2022 | 35805063 | PubTator, text mining | PubMed |
| Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery. | Cancers (Basel) | 2022 | 35805017 | PubTator, text mining | PubMed |
| Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer. | Cancers (Basel) | 2022 | 35804947 | PubTator, text mining | PubMed |
| Strand annealing and motor driven activities of SMARCAL1 and ZRANB3 are stimulated by RAD51 and the paralog complex. | Nucleic Acids Res | 2022 | 35801922 | PubTator, text mining | PubMed |
| Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations. | Curr Opin Oncol | 2022 | 35787597 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. | Front Oncol | 2022 | 35785170 | PubTator, text mining | PubMed |
| Evolving Evidence for the Optimization of Neoadjuvant Therapy in Triple-Negative Breast Cancer. | Breast Cancer (Auckl) | 2022 | 35783596 | PubTator, text mining | PubMed |
| Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer. | Pathol Oncol Res | 2022 | 35783360 | PubTator, text mining | PubMed |
| The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes. | Front Genet | 2022 | 35783256 | PubTator, text mining | PubMed |
| Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion. | Facts Views Vis Obgyn | 2022 | 35781107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=49